RecruitingNCT07774455

Pacritinib Effectiveness in Real-world Settings

Pacritinib Effectiveness in Real-world Settings (PACER)

Sponsor

Swedish Orphan Biovitrum

Enrollment

60 participants

Start Date

Aug 13, 2026

Study Type

OBSERVATIONAL

Conditions

Myelofibrosis (MF)

Summary

This study aims to evaluate real-world treatment patterns and effectiveness of pacritinib, including hematologic and clinical outcomes, and survival through a site-based retrospective chart review of medical records of patients with MF.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Not applicable- observational study for people with myelofibrosis (mf). The study is currently recruiting participants at 3 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.